Company Directory > MedTech > Demant A/S
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Demant A/S and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Demant is a global leader in hearing healthcare and audio technology, founded in 1904. The company develops, manufactures, and distributes innovative hearing aids, diagnostic instruments, and personal communication solutions, operating in over 130 countries with a vertically integrated business model that spans R&D, manufacturing, and a global network of hearing care clinics.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Hearing Healthcare
SIZE & FINANCIALS
Employees:10000+
Revenue:DKK 22.4B (2024)
Founded:1904
Ownership:public
Status:operating
FUNDING
Investors:William Demant Foundation
STOCK
Exchange:NASDAQ Copenhagen
Ticker:DEMANT
Market Cap:DKK 50.74B
PIPELINE
Stage:Commercial
Modalities:Hearing Aids, Diagnostic Equipment, Hearing Implants (divested)
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:William Demant Invest A/S
Subsidiaries:Oticon, Bernafon, Interacoustics, Audika, KIND Group
Key Partnerships:Philips (Hearing Solutions licensee)
COMPETITION
Position:Leader
Competitors:Sonova, WS Audiology, GN Hearing
LEADERSHIP
Key Executives:
Søren Nielsen - President & CEO
Rene Schneider - CFO
LINKS
Website:demant.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Demant A/S. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.